ClariTrial | Search Clinical Trials

Explore/Breast Cancer

Status

Phase

19,193 results for “Breast Cancer”

Page 1 of 1280

Active

A Phase III Study of KN026 in Combination With HB1801 ± Carboplatin as Neoadjuvant Treatment for Early or Locally Advanced HER2-Positive Breast Cancer

Phase 3Early or Locally Advanced HER2-positive Breast Cancer

KN026HB1801Pertuzumab+3 more

Shanghai JMT-Bio Inc.520 participants1 site · ChinaCompletes Dec 2026

Compare CT.gov Full analysis →

Completed

The BurnAlong Pilot Study for Adolescent and Young Adult Cancer Survivors

N/ACancerCancer MetastaticNeoplasms

Virtual group based physical activity (BurnAlong) and Social Media Discussion Board

Cedars-Sinai Medical Center8 participants1 site · United StatesCompletes Jun 2023

Compare CT.gov Full analysis →

Active

CARE (Chemotherapy Alopecia REduction)

N/ABreast CancerBreast - FemaleBreast Cancer Stage I

Scalp Cooling by DigniCap

George Washington University30 participants1 site · United StatesCompletes Sep 2027

Compare CT.gov Full analysis →

UNKNOWN

Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer

N/ABreast Cancer

doxorubicincyclophosphamidepaclitaxel+1 more

Barretos Cancer Hospital80 participants1 site · BrazilCompletes Apr 2012

Compare CT.gov Full analysis →

Active

A Phase I/IIa Trial of HMBD-001 in Advanced HER3 Positive Solid Tumours

Phase 1Phase 2Bladder CancerTriple Negative Breast CancerCastration-resistant Prostate Cancer

HMBD-001HMBD-001 and enzalutamide

Cancer Research UK81 participants4 sites · United KingdomCompletes Nov 2025

Compare CT.gov Full analysis →

Completed

Gene Methylation for Diagnosis of Breast Lesions

N/ABreast Lesions of Uncertain Malignant PotentialPTEN

Gene Methylation Analysis of BRCA1, RASSF1A and PTEN

Institute of Oncology Ljubljana401 participants1 site · SloveniaCompletes Dec 2025

Compare CT.gov Full analysis →

Recruiting

Study of SHR-A1811 Combined With Pyrotinib and Bevacizumab in Advanced Breast Cancer With Brain Metastasis

Phase 1Phase 2Breast Cancer MetastaticBreast Cancer Brain Metastases

SHR-A1811BevacizumabPyrotinib

Fudan University74 participants1 site · ChinaCompletes Aug 2026

Compare CT.gov Full analysis →

Completed

Results posted

Rosuvastatin to Lower Circulating Tissue Factor Bearing Microparticles in Metastatic Breast Cancer

Phase 2Breast Cancer

rosuvastatin

Beth Israel Deaconess Medical Center20 participants2 sites · United StatesCompletes Nov 2013

Compare CT.gov Full analysis →

Terminated

Results posted

Imaging Study for FdCyd and THU Cancer Treatment

Early Phase 1Head and Neck NeoplasmsLung NeoplasmsUrinary Bladder Neoplasms

[F-18]-5-FLUORO-2'-DEOXYCYTIDINETetrahydrouridine intravenous (IV)Tetrahydrouridine (oral)+1 more

National Cancer Institute (NCI)5 participants1 site · United StatesCompletes Aug 2017

Compare CT.gov Full analysis →

Recruiting

Robustness Evaluation of Deep Inspiration Breath-Hold (DIBH) Plans in Internal Mammary Irradiation

N/ABreast Cancer

DIBH with 3mm Gating WindowDIBH with 2 mm Gating WindowDIBH with 1.5 mm Gating Window

Ruijin Hospital25 participants1 site · ChinaCompletes Dec 2026

Compare CT.gov Full analysis →

Active

Trastuzumab Deruxtecan (T-DXd) With or Without Pertuzumab Versus Taxane, Trastuzumab and Pertuzumab in HER2-positive Metastatic Breast Cancer (DESTINY-Breast09)

Phase 3Breast Cancer; HER2-positive; Metastatic

Trastuzumab deruxtecanPlaceboTaxane+2 more

AstraZeneca1,157 participants283 sites · United States, Argentina, BelgiumCompletes Nov 2026

Compare CT.gov Full analysis →

UNKNOWN

Letrozole Plus Oral Cyclophosphamide Plus/Minus Sorafenib as Primary Systemic Treatment in Breast Cancer Patients

Phase 2Breast Cancer

letrozolo+cyclophosphamideletrozolo+sorafenib+cyclophosphamide

University of Turin, Italy190 participants2 sites · ItalyCompletes Jun 2010

Compare CT.gov Full analysis →

Not Yet Recruiting

Gene-edited T Regulatory Cells (CRG-150) for the Treatment of Relapsed/Refractory Malignancies

Phase 1Phase 2HR-positive, HER2-negative Breast CancerTNBC - Triple-Negative Breast CancerProstate Cancer

CRG-150

CoRegen, Inc.67 participantsCompletes Jun 2029

Compare CT.gov Full analysis →

UNKNOWN

Effects of Selected Exercise Program on Microcirculation and Lymphedema in Postmastectomy Patients

N/AMastectomy; Lymphedema

Qigong exercise

Cairo University30 participants1 site · EgyptCompletes May 2022

Compare CT.gov Full analysis →

Not Yet Recruiting

Rising ctDNA to Tailor Endocrine Therapy Switch in Patients With ER+/HER2- Metastatic Breast Cancer.

Phase 3Metastatic Invasive Breast Cancer

Tumor assessmentCompletion of Quality-of-life questionnairesECG+1 more

UNICANCER370 participantsCompletes Jun 2032

Compare CT.gov Full analysis →

1–15 of 19,193

Explore/Breast Cancer

Status

Phase

19,193 results for “Breast Cancer”

Page 1 of 1280

Active

A Phase III Study of KN026 in Combination With HB1801 ± Carboplatin as Neoadjuvant Treatment for Early or Locally Advanced HER2-Positive Breast Cancer

Phase 3Early or Locally Advanced HER2-positive Breast Cancer

KN026HB1801Pertuzumab+3 more

Shanghai JMT-Bio Inc.520 participants1 site · ChinaCompletes Dec 2026

Compare CT.gov Full analysis →

Completed

The BurnAlong Pilot Study for Adolescent and Young Adult Cancer Survivors

N/ACancerCancer MetastaticNeoplasms

Virtual group based physical activity (BurnAlong) and Social Media Discussion Board

Cedars-Sinai Medical Center8 participants1 site · United StatesCompletes Jun 2023

Compare CT.gov Full analysis →

Active

CARE (Chemotherapy Alopecia REduction)

N/ABreast CancerBreast - FemaleBreast Cancer Stage I

Scalp Cooling by DigniCap

George Washington University30 participants1 site · United StatesCompletes Sep 2027

Compare CT.gov Full analysis →

UNKNOWN

Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer

N/ABreast Cancer

doxorubicincyclophosphamidepaclitaxel+1 more

Barretos Cancer Hospital80 participants1 site · BrazilCompletes Apr 2012

Compare CT.gov Full analysis →

Active

A Phase I/IIa Trial of HMBD-001 in Advanced HER3 Positive Solid Tumours

Phase 1Phase 2Bladder CancerTriple Negative Breast CancerCastration-resistant Prostate Cancer

HMBD-001HMBD-001 and enzalutamide

Cancer Research UK81 participants4 sites · United KingdomCompletes Nov 2025

Compare CT.gov Full analysis →

Completed

Gene Methylation for Diagnosis of Breast Lesions

N/ABreast Lesions of Uncertain Malignant PotentialPTEN

Gene Methylation Analysis of BRCA1, RASSF1A and PTEN

Institute of Oncology Ljubljana401 participants1 site · SloveniaCompletes Dec 2025

Compare CT.gov Full analysis →

Recruiting

Study of SHR-A1811 Combined With Pyrotinib and Bevacizumab in Advanced Breast Cancer With Brain Metastasis

Phase 1Phase 2Breast Cancer MetastaticBreast Cancer Brain Metastases

SHR-A1811BevacizumabPyrotinib

Fudan University74 participants1 site · ChinaCompletes Aug 2026

Compare CT.gov Full analysis →

Completed

Results posted

Rosuvastatin to Lower Circulating Tissue Factor Bearing Microparticles in Metastatic Breast Cancer

Phase 2Breast Cancer

rosuvastatin

Beth Israel Deaconess Medical Center20 participants2 sites · United StatesCompletes Nov 2013

Compare CT.gov Full analysis →

Terminated

Results posted

Imaging Study for FdCyd and THU Cancer Treatment

Early Phase 1Head and Neck NeoplasmsLung NeoplasmsUrinary Bladder Neoplasms

[F-18]-5-FLUORO-2'-DEOXYCYTIDINETetrahydrouridine intravenous (IV)Tetrahydrouridine (oral)+1 more

National Cancer Institute (NCI)5 participants1 site · United StatesCompletes Aug 2017

Compare CT.gov Full analysis →

Recruiting

Robustness Evaluation of Deep Inspiration Breath-Hold (DIBH) Plans in Internal Mammary Irradiation

N/ABreast Cancer

DIBH with 3mm Gating WindowDIBH with 2 mm Gating WindowDIBH with 1.5 mm Gating Window

Ruijin Hospital25 participants1 site · ChinaCompletes Dec 2026

Compare CT.gov Full analysis →

Active

Trastuzumab Deruxtecan (T-DXd) With or Without Pertuzumab Versus Taxane, Trastuzumab and Pertuzumab in HER2-positive Metastatic Breast Cancer (DESTINY-Breast09)

Phase 3Breast Cancer; HER2-positive; Metastatic

Trastuzumab deruxtecanPlaceboTaxane+2 more

AstraZeneca1,157 participants283 sites · United States, Argentina, BelgiumCompletes Nov 2026

Compare CT.gov Full analysis →

UNKNOWN

Letrozole Plus Oral Cyclophosphamide Plus/Minus Sorafenib as Primary Systemic Treatment in Breast Cancer Patients

Phase 2Breast Cancer

letrozolo+cyclophosphamideletrozolo+sorafenib+cyclophosphamide

University of Turin, Italy190 participants2 sites · ItalyCompletes Jun 2010

Compare CT.gov Full analysis →

Not Yet Recruiting

Gene-edited T Regulatory Cells (CRG-150) for the Treatment of Relapsed/Refractory Malignancies

Phase 1Phase 2HR-positive, HER2-negative Breast CancerTNBC - Triple-Negative Breast CancerProstate Cancer

CRG-150

CoRegen, Inc.67 participantsCompletes Jun 2029

Compare CT.gov Full analysis →

UNKNOWN

Effects of Selected Exercise Program on Microcirculation and Lymphedema in Postmastectomy Patients

N/AMastectomy; Lymphedema

Qigong exercise

Cairo University30 participants1 site · EgyptCompletes May 2022

Compare CT.gov Full analysis →

Not Yet Recruiting

Rising ctDNA to Tailor Endocrine Therapy Switch in Patients With ER+/HER2- Metastatic Breast Cancer.

Phase 3Metastatic Invasive Breast Cancer

Tumor assessmentCompletion of Quality-of-life questionnairesECG+1 more

UNICANCER370 participantsCompletes Jun 2032

Compare CT.gov Full analysis →

1–15 of 19,193